These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 2546480)
1. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability. Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480 [TBL] [Abstract][Full Text] [Related]
2. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods. Kogan MJ; Al Razi J; Pierson DJ; Willson NJ J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956 [TBL] [Abstract][Full Text] [Related]
3. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. Fraser AD; Worth D Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035 [TBL] [Abstract][Full Text] [Related]
4. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Fraser AD; Worth D Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292 [TBL] [Abstract][Full Text] [Related]
5. Detection and confirmation of urinary cannabinoids. Sutheimer CA; Yarborough R; Hepler BR; Sunshine I J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071 [TBL] [Abstract][Full Text] [Related]
6. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens. Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715 [TBL] [Abstract][Full Text] [Related]
7. Laboratory evaluation of immunoassay kits for the detection of cannabinoids in biological fluids. Peat MA; Finkle BS; Deyman ME NIDA Res Monogr; 1982; 42():85-98. PubMed ID: 6817140 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of various immunologic methods with a GC-MS analysis in cannabinoid detection in urine]. Käferstein H; Sticht G; Staak M Beitr Gerichtl Med; 1989; 47():115-22. PubMed ID: 2684146 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Abbott fluorescence polarization immunoassay (FPIA) and Roche radioimmunoassay for the analyses of cannabinoids in urine specimens. Budgett WT; Levine B; Xu A; Smith ML J Forensic Sci; 1992 Mar; 37(2):632-5. PubMed ID: 1500902 [TBL] [Abstract][Full Text] [Related]
10. Validated gas chromatographic-mass spectrometric analysis of urinary cannabinoids purified with a calcium-hardened beta-cyclodextrin polymer. Moon JY; Kim JY; Moon MH; Chung BC; In MK; Choi MH J Chromatogr A; 2008 Sep; 1204(1):87-92. PubMed ID: 18692852 [TBL] [Abstract][Full Text] [Related]
11. Urinary cannabinoids in monitoring abstinence in a drug abuse treatment program. Schwartz RH; Willette RE; Hayden GF; Bogema S; Thorne MM; Hicks J Arch Pathol Lab Med; 1987 Aug; 111(8):708-11. PubMed ID: 3307687 [TBL] [Abstract][Full Text] [Related]
12. Comparison of six cannabinoid metabolite assays. Frederick DL; Green J; Fowler MW J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunoassay methods for the screening of cocaine metabolites in urine. Baugh LD; Allen EE; Liu RH; Langner JG; Fentress JC; Chadha SC; Cook LF; Walia AS J Forensic Sci; 1991 Jan; 36(1):79-85. PubMed ID: 2007883 [TBL] [Abstract][Full Text] [Related]
14. Comparison between GC-MS and the EMIT II, Abbott ADx, and Roche OnLine immunoassays for the determination of THCCOOH. Kintz P; Machart D; Jamey C; Mangin P J Anal Toxicol; 1995 Sep; 19(5):304-6. PubMed ID: 7500617 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay. ElSohly MA; Jones AB; ElSohly HN J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818 [TBL] [Abstract][Full Text] [Related]
16. Comparative results with five cannabinoid immunoassay systems at the screening threshold of 100 micrograms/L. Wells DJ; Barnhill MT Clin Chem; 1989 Nov; 35(11):2241-3. PubMed ID: 2582623 [TBL] [Abstract][Full Text] [Related]
17. Urine cannabinoid analysis: an integrated multi-method approach. Black DL; Goldberger BA; Isenschmid DS; White SM; Caplan YH J Anal Toxicol; 1984; 8(5):224-7. PubMed ID: 6389979 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in hair: strategy to prove marijuana/hashish consumption. Uhl M; Sachs H Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086 [TBL] [Abstract][Full Text] [Related]
19. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results. Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522 [TBL] [Abstract][Full Text] [Related]
20. [Detection of cannabinoids in urine]. Kataev SS; Zelenina NB; Melent'ev AB; Zalesova VA; Kurdina LN Sud Med Ekspert; 2005; 48(2):35-8. PubMed ID: 15881141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]